Recent Finacing
Recent Raise
InnaVirVax is a France-based biotech developing immunotherapies for infectious and chronic diseases; its VAC-3S HIV immunotherapy is in randomized Phase 2a clinical trials across multiple European centers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
